Olivia Ventures Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Due Diligence for Asset Managers
Analyze the public filings of asset managers
Dive into the EDGAR, IAPD, CAFR source data
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Olivia Ventures Inc
TickerCMPX
CIK #0001738021
CUSIP20454B104
SectorReal Estate & Construction - Blank Checks
Address2255 Glades Road Suite 324A, Boca Raton, FL 33431
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Compass Therapeutics Inc 2020-07-01 60.5 M Exemption: 506(b) · Remaining: $9,517,790 · Duration: One year or less · Commission: $4,700,000 · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001738021] 10-K
[0001738021] 10-Q
[0001738021] 3
[0001738021] 4
[0001738021] 8-K
[0001738021] D
[0001738021] SC 13D
[0001738021] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
BlackRock Inc Compass Therapeutics Inc [2026-01-21] 0.0
Vivo Opportunity Fund Holdings LP Compass Therapeutics Inc [2025-11-14] 0.0
Biotechnology Value Fund L P Compass Therapeutics Inc [2025-10-29] 0.0
Suvretta Capital Management LLC Compass Therapeutics Inc [2025-08-13] 0.0
MPM Bioimpact LLC Compass Therapeutics Inc [2025-02-14] 0.0
BlackRock Inc Compass Therapeutics Inc [2025-02-04] 0.0
Tang Capital Management LLC Compass Therapeutics Inc [2025-01-16] 0.0
Blackstone Holdings II LP Compass Therapeutics Inc [2024-08-02] 81942.6
Janus Henderson Group PLC Compass Therapeutics Inc [2024-02-01] 6.0
Adage Capital Partners GP LLC Compass Therapeutics Inc [2023-11-27] 5.66
Commander Aggregator LP Compass Therapeutics Inc [2022-11-14] 6.17
Rock Springs Capital Management LP Compass Therapeutics Inc [2021-12-30] 5.43
Foresite Capital Fund V LP Compass Therapeutics Inc [2021-11-12] 4.5
FMR LLC Compass Therapeutics Inc [2020-08-10] 0.0
OrbiMed Advisors LLC Compass Therapeutics Inc [2020-06-29] 24.4
Anderson Errik Compass Therapeutics Inc [2020-06-29] 0.0
FMR LLC Compass Therapeutics Inc [2020-06-29] 0.0
Schuetz Thomas J Compass Therapeutics Inc [2020-06-26] 8.7
Ferneau Philip Compass Therapeutics Inc [2020-06-26] 0.3
Tompkins Mark N Olivia Ventures Inc [2019-02-13] 5.0
Form 3/4/5 Filer 2011 - 2026
Compass Therapeutics Inc
Anderman Jonathan
Lerner Neil
Schuetz Thomas J
Sirard Cynthia
Prasad Arjun
Boylan James P
Gordon Carl L
Ferneau Philip
Shin Barry
Lindahl Richard S
Chiniara Ellen
Gray Mary Ann
OrbiMed Capital GP VI LLC
OrbiMed Advisors LLC
OrbiMed Genesis GP LLC
Bisker-Leib Vered
Wurzer David M
OrbiMed Capital GP V LLC
Kaplan Brett
Squinto Stephen P
Kalled Susan
Toledano Miranda Jayne
Anderson Errik
Sunderland Julie
Jacobs Ian Seth
Tompkins Mark N
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Schuetz Thomas J
Common Stock
2026-02-08 Tax withheld 36,687 $6.52 239,199
Schuetz Thomas J
Common Stock
2026-01-09 Tax withheld 46,777 $5.35 250,257
Shin Barry
Common Stock
2026-01-02 Grant 125,000 $5.17 646,250
Schuetz Thomas J
Common Stock
2026-01-02 Grant 250,000 $5.17 1,292,500
Lerner Neil
Common Stock
2026-01-02 Grant 62,500 $5.17 323,125
Anderman Jonathan
Common Stock
2026-01-02 Grant 150,000 $5.17 775,500
Shin Barry
Stock Option (Right to Buy) · derivative
2026-01-02 Grant 670,000 $0.00
Sirard Cynthia
STOCK OPTION (RIGHT TO BUY) · derivative
2026-01-02 Grant 1,000,000 $0.00
Schuetz Thomas J
Stock Option (Right to Buy) · derivative
2026-01-02 Grant 2,000,000 $0.00
Prasad Arjun
STOCK OPTION (RIGHT TO BUY) · derivative
2026-01-02 Grant 1,000,000 $0.00
Lindahl Richard S
Stock Option (Right to Buy) · derivative
2026-01-02 Grant 90,000 $0.00
Chiniara Ellen
Stock Option (Right to Buy) · derivative
2026-01-02 Grant 90,000 $0.00
Lerner Neil
Stock Option (Right to Buy) · derivative
2026-01-02 Grant 435,000 $0.00
Gray Mary Ann
Stock Option (Right to Buy) · derivative
2026-01-02 Grant 90,000 $0.00
Boylan James P
Stock Option (Right to Buy) · derivative
2026-01-02 Grant 90,000 $0.00
Gordon Carl L
Stock Option (Right to Buy) · derivative
2026-01-02 Grant 90,000 $0.00
Ferneau Philip
Stock Option (Right to Buy) · derivative
2026-01-02 Grant 90,000 $0.00
Anderman Jonathan
Stock Option (Right to Buy) · derivative
2026-01-02 Grant 720,000 $0.00
Schuetz Thomas J
Common Stock
2025-11-16 Tax withheld 44,025 $4.83 212,641
Schuetz Thomas J
Common Stock
2025-05-27 Buy 10,000 $2.11 21,100
showing 20 of 137 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 204 176,720,053
2025-12-31 173 164,120,161
2025-09-30 125 154,062,474
2025-06-30 105 110,853,377
2025-03-31 120 114,106,120
2024-12-31 93 101,374,131
2024-09-30 80 92,217,843
2024-06-30 83 92,907,687
2024-03-31 79 94,919,326
2023-12-31 78 86,402,379
2023-09-30 77 89,720,729
2023-06-30 74 90,479,072
Form 13F Holdings
Firm Period DFND Voting Shares
Wealth Enhancement Advisory Services LLC [2026-06-30] SOLE 3,165 83,567
Wealthcare Advisory Partners LLC [2026-06-30] SOLE 0 60,962
Sequoia Financial Advisors LLC [2026-06-30] SOLE 0 44,980
Independent Financial Group LLC [2026-06-30] SOLE 0 22,779
Wealthcare Capital Partners LLC [2026-06-30] SOLE 0 19,654
Merit Financial Group LLC [2026-06-30] OTR 0 13,322
Merit Financial Group LLC [2026-06-30] SOLE 75 10,352
True Wealth Design LLC [2026-06-30] SOLE 0 1,557
Fortitude Family Office LLC [2026-06-30] SOLE 1,481 1,481
Farther Finance Advisors LLC [2026-06-30] SOLE 0 1,264
Gamma Investing LLC [2026-06-30] DFND 442 442
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com